Literature DB >> 9090470

Cytokine profile in autosomal dominant polycystic kidney disease.

M Merta1, V Tesar, T Zima, M Jirsa, R Rysavá, J Zabka.   

Abstract

To elucidate the pathogenetic mechanism of renal parenchymal injury in autosomal dominant polycystic kidney disease (ADPKD) patients, typically characterized by renal cystic changes paralleled by interstitial inflammation and gradual fibrotic changes, the role of selected inflammatory mediators was evaluated in a group of ADPKD patients with normal glomerular filtration rate. The plasma concentrations of IL-6, IL-8, ICAM-1 and VCAM-1 (which may reflect systemic response to inflammation/infection) were increased in the ADPKD patient group. Coupled with decreased urinary excretion of the IL-1 receptor antagonist (which exerts an anti-inflammatory role), these results suggest that even in overt infection free status, the proinflammatory system is more activated and anti-inflammatory defence system weakened in ADPKD subjects. Our data support the current view that cytokines are candidate contributors to pathogenesis of ADPKD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9090470     DOI: 10.1080/15216549700201651

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  14 in total

Review 1.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

2.  Interleukin-1 receptor activation aggravates autosomal dominant polycystic kidney disease by modulating regulated necrosis.

Authors:  Bo Yang; Lili Fu; Jamie R Privratsky; Xiaohan Lu; Jiafa Ren; Changlin Mei; Steven D Crowley
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-29

3.  Endothelial dysfunction and oxidative stress in polycystic kidney disease.

Authors:  Jelena Klawitter; Berenice Y Reed-Gitomer; Kim McFann; Alexander Pennington; Jost Klawitter; Kaleab Z Abebe; Jacek Klepacki; Melissa A Cadnapaphornchai; Godela Brosnahan; Michel Chonchol; Uwe Christians; Robert W Schrier
Journal:  Am J Physiol Renal Physiol       Date:  2014-09-18

4.  Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.

Authors:  Kevin S Heffernan; Jeffrey T Kuvin; Mark J Sarnak; Ronald D Perrone; Dana C Miskulin; Darya Rudym; Priya Chandra; Richard H Karas; Vandana Menon
Journal:  Nephrol Dial Transplant       Date:  2011-02-03       Impact factor: 5.992

5.  Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.

Authors:  Linda Xiaoyan Li; Lucy X Fan; Julie Xia Zhou; Jared J Grantham; James P Calvet; Julien Sage; Xiaogang Li
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

6.  Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease.

Authors:  Vandana Menon; Darya Rudym; Priya Chandra; Dana Miskulin; Ronald Perrone; Mark Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-09       Impact factor: 8.237

7.  Epithelial morphogenesis of MDCK cells in three-dimensional collagen culture is modulated by interleukin-8.

Authors:  Erika K Wells; OrLando Yarborough; Richard P Lifton; Lloyd G Cantley; Michael J Caplan
Journal:  Am J Physiol Cell Physiol       Date:  2013-03-13       Impact factor: 4.249

8.  Bioactive lipid mediators in polycystic kidney disease.

Authors:  Jelena Klawitter; Jost Klawitter; Kim McFann; Alexander T Pennington; Kaleab Z Abebe; Godela Brosnahan; Melissa A Cadnapaphornchai; Michel Chonchol; Berenice Gitomer; Uwe Christians; Robert W Schrier
Journal:  J Lipid Res       Date:  2013-12-16       Impact factor: 5.922

9.  Tg737 signaling is required for hypoxia-enhanced invasion and migration of hepatoma cells.

Authors:  Nan You; Weihui Liu; Lijun Tang; Xiao Zhong; Ru Ji; Ning Zhang; Desheng Wang; Yong He; Kefeng Dou; Kaishan Tao
Journal:  J Exp Clin Cancer Res       Date:  2012-09-13

10.  TWEAK Signaling Pathway Blockade Slows Cyst Growth and Disease Progression in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Adrian Cordido; Laura Nuñez-Gonzalez; Julio M Martinez-Moreno; Olaya Lamas-Gonzalez; Laura Rodriguez-Osorio; Maria Vanessa Perez-Gomez; Diego Martin-Sanchez; Patricia Outeda; Marco Chiaravalli; Terry Watnick; Alessandra Boletta; Candido Diaz; Angel Carracedo; Ana B Sanz; Alberto Ortiz; Miguel A Garcia-Gonzalez
Journal:  J Am Soc Nephrol       Date:  2021-06-21       Impact factor: 14.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.